Dyadic International (DYAI) 0.9900 $DYAI
Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors
PR Newswire - Mon Jan 12, 7:40AM CST
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins, announced today the appointment of Michael Tarnok as the company's Chairman of the Board of Directors. Mr. Tarnok will continue to serve on the company's audit and compensation committees.
KERX: 11.63 (-0.60)
Dyadic International Extends Debt Maturity Date On Note Payable
PR Newswire - Mon Jan 05, 3:15PM CST
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has entered into an agreement to extend the maturity date of the $1.4 million non-convertible 9.5% note payable (the "Debt" to January 1, 2016. All other terms and conditions of the Debt remain unchanged.
Dyadic International's (DYAI) CEO Mark Emalfarb on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 9:32PM CST
Dyadic International Reports Q3 2014 Financial Results
PR Newswire - Thu Nov 13, 3:15PM CST
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, today announced financial results for the third quarter ended September 30, 2014.
New U.S. Patent Issued To Dyadic International
PR Newswire - Wed Nov 12, 8:34AM CST
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has been issued U.S. Patent No. 8,871,493 "Transformation system in the field of filamentous fungal hosts" by the United States Patent and Trademark Office ("USPTO" .
Dyadic International To Present At Two Conferences In November 2014
PR Newswire - Mon Nov 03, 3:48PM CST
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that the Company will present at the following conferences in November:
Dyadic International Extends All Convertible Debt Maturity Dates
PR Newswire - Thu Oct 30, 4:42PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has entered into agreements with the holders of all of its outstanding 2010 and 2011 8% convertible subordinated notes (the "Convertible Debt" to extend their maturity dates to January 1, 2016.
Dyadic International To Announce Third Quarter 2014 Financial Results And Host Conference Call On Thursday, November 13, 2014
PR Newswire - Thu Oct 30, 3:50PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for the third quarter ended September 30, 2014 after market close on Thursday, November 13, 2014 and will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results.
Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes
PR Newswire - Wed Oct 01, 7:30AM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company with patented and proprietary technology used to develop and produce enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes industries, today announced the receipt of a $500,000 licensing payment from Abengoa Bioenergy for commercial scale production of Abengoa's proprietary cellulase enzymes, used for converting biomass into ethanol, developed under Abengoa's license agreement with Dyadic.
Analyzing the Market for Cellulosic Ethanol - 2014
M2 - Wed Sep 17, 8:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/38rww8/analyzing_the) has announced the addition of the "Analyzing the Market for Cellulosic Ethanol - 2014" report to their offering. This report is a complete handbook on this dynamic fuel source and its position in the global energy scenario. The report builds on the global energy industry and the consumption patterns which are fed by the traditional sources like Oil, Coal, Natural Gas, Nuclear Energy and Hydroelectricity. The report also presents a track on the global energy consumption patterns along with the resources being used for them. Taking into consideration the revenue cycles in the global energy markets, the report explains the revenue derived from these demand patterns from traditional sources as well as hydroelectric and wind energy. The report further also details each source individually. Taking a contrasting view point the report presents an in depth analysis of the global energy crisis and the growing recognition of unconventional energy sources for arresting this crisis. Key Topics Covered: A. Executive Summary B. Analyzing the Global Energy Industry C. Revenue Returns on Global Energy Markets D. Global Energy Demand & Supply Dynamics E. Looking at the Global Energy Crisis F. Emergence of Ethanol as an Energy Source G. Introduction to Cellulosic Ethanol H. Analyzing the Major Conversion Technologies: Producing Ethanol from Cellulosic Feedstocks I. Analyzing Ethanol Production from Different Feedstocks J. Analyzing the Utility of Ethanol in Transportation K. Commercializing Cellulosic Ethanol L. Factors Impact Growth of the Industry M. Challenges & Issues Facing the Industry N. Technological Patterns Prominent in the Industry O. Role of Industrial Biotechnology in the Development of Cellulosic Ethanol P. Production Patterns Q. Influence of Cellulosic Ethanol on the Farm Economy R. Ethanol Production and Use - Impact on the Economy S. Analyzing the Economics of Ethanol Production T. Analyzing the Regulatory Framework U. Government Incentives & Support Mechanisms V. Leading Industry Players - Abengoa Bioenergy Corporation - Archer Daniels Midland Co. - Aventine Renewable Energy Holdings - Cargill - Codexis, Inc - Dyadic International, Inc - Genencor International - Green Plains Renewable Energy. - Iogen Corporation - Lignol - Mascoma Corporation - NatureWorks, LLC - Novozymes - Pacific Ethanol, Inc. - Renova Energy (Wyoming Ethanol) - SunOpta - Tate & Lyle - The Andersons Inc. - U.S. BioEnergy Corporation - VeraSun Energy Corporation - Verenium - Xethanol BioFuels, LLC For more information visit http://www.researchandmarkets.com/research/38...lyzing_the
ADM: 48.10 (+0.66), GPRE: 25.50 (-0.56), CDXS: 3.42 (+0.07)
Dyadic International Files Form 10 Registration Statement
PR Newswire - Mon Aug 18, 7:47AM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has filed a Registration Statement on Form 10 with the U.S. Securities and Exchange Commission (the "SEC" .
Dyadic And CIMV Enter Into Collaboration To Commercialize Second Generation Biofuel Technology
PR Newswire - Tue Aug 05, 7:30AM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has signed a collaboration agreement to commercialize second generation biofuel and bio-based chemical technology with Compagnie Industrielle de la Matiere Vegetale ("CIMV" , a pioneer in developing processes for the production of biofuels and bio-based chemicals.
Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014
PR Newswire - Fri Aug 01, 7:30AM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for the second quarter ended June 30, 2014 after market close on Thursday, August 14, 2014 and will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results.
Thomas Dubinski joins Dyadic as Chief Financial Officer
PR Newswire - Wed Jul 30, 7:30AM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), is a global biotechnology company whose patented and proprietary technologies are used to discover, develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today the appointment of Thomas "Tom" Dubinski as Vice President and Chief Financial Officer. Tom will be responsible for leading the financial and information technology operations for Dyadic and will succeed Michael Faby effective August 4, 2014.
Dyadic International Announces Participation In Bakenzyme Project
PR Newswire - Wed Jul 09, 3:15PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new Bakenzyme project. In collaboration with several industry partners, the Bakenzyme project seeks to develop a novel, pure and widely applicable xylanase-oxidase enzyme product for the baking industry.
2014 Report on the International Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Market - Forecasts to 2018
PR Newswire Europe - Mon Jun 30, 12:00PM CDT
Research and Markets (http://www.researchandmarkets.com/research/qzldlf/alcohol_and [http://www.researchandmarkets.com/research/qzldlf/alcohol_and]) has announced the addition of the "2014 Report on the International Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Market - Forecasts to 2018" [http://www.researchandmarkets.com/research/qzldlf/alcohol_and] report to their offering.
CDXS: 3.42 (+0.07)
Global Carbohydrase Market Forecasts & Opportunities, 2019
M2 - Wed Jun 25, 8:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tpd8bc/carbohydrase) has announced the addition of the "Carbohydrase Market by Applications, Type, Source and Geography - Global Trends & Forecasts to 2019" report to their offering. Global industries are speedily inculcating the usage of enzymes in light of the numerous advantages they offer. The enzyme group considered in this study is carbohydrases, which include a large family of amylases, cellulases, pectinases, lactase, mannanases, pullulanases, and others. Carbohydrases market products find application in diverse industrial markets such as food, beverages, animal feed, pharmaceuticals, textile and leather, pulp and paper, bio-fuel, and many more. Industrial processes stand to become more environment-friendly with the usage of carbohydrase, as they account for low greenhouse gas emissions and less raw material wastage. With the advent of new production strains using genetically modified microorganisms, large scale manufacturing of carbohydrase is possible, with functions aimed at specific requirements without the risk of any undesired side-effects. The three major applications of carbohydrase include food & beverage, animal feed, and pharmaceuticals. Scope of the Report Application - Food & Beverage - Animal Feed - Pharmaceuticals - Others Type - Amylases - Cellulases - Others Source - Microorganisms - Animals - Plants Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Total Addressable Market 5 Market Overview 6 Carbohydrase Market,By Geography 7 Carbohydrase Market, By Application 8 Carbohydrases: Grain Processing Market Overview 9 Carbohydrase Market, By Type 10 Carbohydrases Market, By Source 11 Competitive Landscape 12 Company Profiles - AB Enzymes Gmbh - Advanced Enzymes - Amano Enzyme Inc. - CHR. Hansen Holding A/S - Dyadic International, Inc. - E.I. Dupont De Nemours & Co. (Dupont) Msds. - Novozymes - Royal DSM - Specialty Enzymes - Verenium For more information visit http://www.researchandmarkets.com/research/tp...rbohydrase
2014 Report on the International Protein Hydrolysis Enzymes (Microorganisms, Animals, Plants) Market - Forecasts to 2019
M2 - Tue Jun 24, 5:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dkhbw6/protein) has announced the addition of the "2014 Report on the International Protein Hydrolysis Enzymes (Microorganisms, Animals, Plants) Market - Forecasts to 2019" report to their offering. The enzymes which are very specific to protein hydrolysis are protease enzymes and they are classified under the hydrolases group. Protease enzymes refer to a group of enzymes whose catalytic function is to hydrolyze (breakdown) proteins. These enzymes represent one of the three largest groups of industrial enzymes; others being amylases and lipases. Protease enzymes mainly find their applications in detergents, food, pharmaceuticals, and bioremediation processes. The worldwide requirement of enzymes for individual applications varies considerably. Technical enzymes for detergent, paper & pulp, and textile manufacturing have the largest segment with approximately 52% market share with the largest share of the enzymes market held by alkaline proteases. The global protease enzymes market is growing at a CAGR of 5.3% from 2014 to 2019. Western Europe and the U.S. have almost reached maturity with regard to the protease enzymes detergent market and the trend is shifting towards the consumption of protease enzymes in the pharmaceutical industry. On the other hand, Asia-Pacific and Rest of the World (ROW) regions, which are still developing and modernizing the laundry industry protease enzymes, are growing at a healthy CAGR in these countries. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Total Addressable Market 5 Premium Insights 6 Protein Hydrolysis Enzymes Market, By Source 7 Protein Hydrolysis Enzymes Market, By Application 8 Protein Hydrolysis Enzymes Market, By Geography 9 Competitive Landscape 10 Company Profile Companies Mentioned: - Ab Enzymes - Advanced Enzymes - Amano Enzymes - Dyadic International, Inc. - E.I. Dupont De Nemours & Company - Jiangsu Boli Bioproducts Co., Ltd - Novozymes - Royal Dsm - Solvay Enzymes - Specialty Enzymes & Biotechnologies Co. For more information visit http://www.researchandmarkets.com/research/dkhbw6/protein
Dyadic Added to Biofuel Digest Index of Bioeconomy Stocks
PR Newswire - Mon Jun 16, 3:15PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins, announced today that Biofuels Digest has selected Dyadic to be included in its Biofuel Digest Index as part of the annual rebalancing of publicly traded stocks included in the index.
Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors
PR Newswire - Mon Jan 12, 7:40AM CST
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins, announced today the appointment of Michael Tarnok as the company's Chairman of the Board of Directors. Mr. Tarnok will continue to serve on the company's audit and compensation committees. KERX: 11.63 (-0.60)
Dyadic International Extends Debt Maturity Date On Note Payable
PR Newswire - Mon Jan 05, 3:15PM CST
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has entered into an agreement to extend the maturity date of the $1.4 million non-convertible 9.5% note payable (the "Debt" to January 1, 2016. All other terms and conditions of the Debt remain unchanged. Dyadic International's (DYAI) CEO Mark Emalfarb on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 9:32PM CST
Dyadic International Reports Q3 2014 Financial Results
PR Newswire - Thu Nov 13, 3:15PM CST
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, today announced financial results for the third quarter ended September 30, 2014. New U.S. Patent Issued To Dyadic International
PR Newswire - Wed Nov 12, 8:34AM CST
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has been issued U.S. Patent No. 8,871,493 "Transformation system in the field of filamentous fungal hosts" by the United States Patent and Trademark Office ("USPTO" . Dyadic International To Present At Two Conferences In November 2014
PR Newswire - Mon Nov 03, 3:48PM CST
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that the Company will present at the following conferences in November: Dyadic International Extends All Convertible Debt Maturity Dates
PR Newswire - Thu Oct 30, 4:42PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has entered into agreements with the holders of all of its outstanding 2010 and 2011 8% convertible subordinated notes (the "Convertible Debt" to extend their maturity dates to January 1, 2016. Dyadic International To Announce Third Quarter 2014 Financial Results And Host Conference Call On Thursday, November 13, 2014
PR Newswire - Thu Oct 30, 3:50PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for the third quarter ended September 30, 2014 after market close on Thursday, November 13, 2014 and will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results. Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes
PR Newswire - Wed Oct 01, 7:30AM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company with patented and proprietary technology used to develop and produce enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes industries, today announced the receipt of a $500,000 licensing payment from Abengoa Bioenergy for commercial scale production of Abengoa's proprietary cellulase enzymes, used for converting biomass into ethanol, developed under Abengoa's license agreement with Dyadic. Analyzing the Market for Cellulosic Ethanol - 2014
M2 - Wed Sep 17, 8:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/38rww8/analyzing_the) has announced the addition of the "Analyzing the Market for Cellulosic Ethanol - 2014" report to their offering. This report is a complete handbook on this dynamic fuel source and its position in the global energy scenario. The report builds on the global energy industry and the consumption patterns which are fed by the traditional sources like Oil, Coal, Natural Gas, Nuclear Energy and Hydroelectricity. The report also presents a track on the global energy consumption patterns along with the resources being used for them. Taking into consideration the revenue cycles in the global energy markets, the report explains the revenue derived from these demand patterns from traditional sources as well as hydroelectric and wind energy. The report further also details each source individually. Taking a contrasting view point the report presents an in depth analysis of the global energy crisis and the growing recognition of unconventional energy sources for arresting this crisis. Key Topics Covered: A. Executive Summary B. Analyzing the Global Energy Industry C. Revenue Returns on Global Energy Markets D. Global Energy Demand & Supply Dynamics E. Looking at the Global Energy Crisis F. Emergence of Ethanol as an Energy Source G. Introduction to Cellulosic Ethanol H. Analyzing the Major Conversion Technologies: Producing Ethanol from Cellulosic Feedstocks I. Analyzing Ethanol Production from Different Feedstocks J. Analyzing the Utility of Ethanol in Transportation K. Commercializing Cellulosic Ethanol L. Factors Impact Growth of the Industry M. Challenges & Issues Facing the Industry N. Technological Patterns Prominent in the Industry O. Role of Industrial Biotechnology in the Development of Cellulosic Ethanol P. Production Patterns Q. Influence of Cellulosic Ethanol on the Farm Economy R. Ethanol Production and Use - Impact on the Economy S. Analyzing the Economics of Ethanol Production T. Analyzing the Regulatory Framework U. Government Incentives & Support Mechanisms V. Leading Industry Players - Abengoa Bioenergy Corporation - Archer Daniels Midland Co. - Aventine Renewable Energy Holdings - Cargill - Codexis, Inc - Dyadic International, Inc - Genencor International - Green Plains Renewable Energy. - Iogen Corporation - Lignol - Mascoma Corporation - NatureWorks, LLC - Novozymes - Pacific Ethanol, Inc. - Renova Energy (Wyoming Ethanol) - SunOpta - Tate & Lyle - The Andersons Inc. - U.S. BioEnergy Corporation - VeraSun Energy Corporation - Verenium - Xethanol BioFuels, LLC For more information visit http://www.researchandmarkets.com/research/38...lyzing_the
ADM: 48.10 (+0.66), GPRE: 25.50 (-0.56), CDXS: 3.42 (+0.07)
Dyadic International Files Form 10 Registration Statement
PR Newswire - Mon Aug 18, 7:47AM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has filed a Registration Statement on Form 10 with the U.S. Securities and Exchange Commission (the "SEC" . Dyadic And CIMV Enter Into Collaboration To Commercialize Second Generation Biofuel Technology
PR Newswire - Tue Aug 05, 7:30AM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has signed a collaboration agreement to commercialize second generation biofuel and bio-based chemical technology with Compagnie Industrielle de la Matiere Vegetale ("CIMV" , a pioneer in developing processes for the production of biofuels and bio-based chemicals. Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014
PR Newswire - Fri Aug 01, 7:30AM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for the second quarter ended June 30, 2014 after market close on Thursday, August 14, 2014 and will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results. Thomas Dubinski joins Dyadic as Chief Financial Officer
PR Newswire - Wed Jul 30, 7:30AM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), is a global biotechnology company whose patented and proprietary technologies are used to discover, develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today the appointment of Thomas "Tom" Dubinski as Vice President and Chief Financial Officer. Tom will be responsible for leading the financial and information technology operations for Dyadic and will succeed Michael Faby effective August 4, 2014. Dyadic International Announces Participation In Bakenzyme Project
PR Newswire - Wed Jul 09, 3:15PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new Bakenzyme project. In collaboration with several industry partners, the Bakenzyme project seeks to develop a novel, pure and widely applicable xylanase-oxidase enzyme product for the baking industry. 2014 Report on the International Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Market - Forecasts to 2018
PR Newswire Europe - Mon Jun 30, 12:00PM CDT
Research and Markets (http://www.researchandmarkets.com/research/qzldlf/alcohol_and [http://www.researchandmarkets.com/research/qzldlf/alcohol_and]) has announced the addition of the "2014 Report on the International Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Market - Forecasts to 2018" [http://www.researchandmarkets.com/research/qzldlf/alcohol_and] report to their offering.
CDXS: 3.42 (+0.07)
Global Carbohydrase Market Forecasts & Opportunities, 2019
M2 - Wed Jun 25, 8:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tpd8bc/carbohydrase) has announced the addition of the "Carbohydrase Market by Applications, Type, Source and Geography - Global Trends & Forecasts to 2019" report to their offering. Global industries are speedily inculcating the usage of enzymes in light of the numerous advantages they offer. The enzyme group considered in this study is carbohydrases, which include a large family of amylases, cellulases, pectinases, lactase, mannanases, pullulanases, and others. Carbohydrases market products find application in diverse industrial markets such as food, beverages, animal feed, pharmaceuticals, textile and leather, pulp and paper, bio-fuel, and many more. Industrial processes stand to become more environment-friendly with the usage of carbohydrase, as they account for low greenhouse gas emissions and less raw material wastage. With the advent of new production strains using genetically modified microorganisms, large scale manufacturing of carbohydrase is possible, with functions aimed at specific requirements without the risk of any undesired side-effects. The three major applications of carbohydrase include food & beverage, animal feed, and pharmaceuticals. Scope of the Report Application - Food & Beverage - Animal Feed - Pharmaceuticals - Others Type - Amylases - Cellulases - Others Source - Microorganisms - Animals - Plants Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Total Addressable Market 5 Market Overview 6 Carbohydrase Market,By Geography 7 Carbohydrase Market, By Application 8 Carbohydrases: Grain Processing Market Overview 9 Carbohydrase Market, By Type 10 Carbohydrases Market, By Source 11 Competitive Landscape 12 Company Profiles - AB Enzymes Gmbh - Advanced Enzymes - Amano Enzyme Inc. - CHR. Hansen Holding A/S - Dyadic International, Inc. - E.I. Dupont De Nemours & Co. (Dupont) Msds. - Novozymes - Royal DSM - Specialty Enzymes - Verenium For more information visit http://www.researchandmarkets.com/research/tp...rbohydrase
2014 Report on the International Protein Hydrolysis Enzymes (Microorganisms, Animals, Plants) Market - Forecasts to 2019
M2 - Tue Jun 24, 5:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dkhbw6/protein) has announced the addition of the "2014 Report on the International Protein Hydrolysis Enzymes (Microorganisms, Animals, Plants) Market - Forecasts to 2019" report to their offering. The enzymes which are very specific to protein hydrolysis are protease enzymes and they are classified under the hydrolases group. Protease enzymes refer to a group of enzymes whose catalytic function is to hydrolyze (breakdown) proteins. These enzymes represent one of the three largest groups of industrial enzymes; others being amylases and lipases. Protease enzymes mainly find their applications in detergents, food, pharmaceuticals, and bioremediation processes. The worldwide requirement of enzymes for individual applications varies considerably. Technical enzymes for detergent, paper & pulp, and textile manufacturing have the largest segment with approximately 52% market share with the largest share of the enzymes market held by alkaline proteases. The global protease enzymes market is growing at a CAGR of 5.3% from 2014 to 2019. Western Europe and the U.S. have almost reached maturity with regard to the protease enzymes detergent market and the trend is shifting towards the consumption of protease enzymes in the pharmaceutical industry. On the other hand, Asia-Pacific and Rest of the World (ROW) regions, which are still developing and modernizing the laundry industry protease enzymes, are growing at a healthy CAGR in these countries. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Total Addressable Market 5 Premium Insights 6 Protein Hydrolysis Enzymes Market, By Source 7 Protein Hydrolysis Enzymes Market, By Application 8 Protein Hydrolysis Enzymes Market, By Geography 9 Competitive Landscape 10 Company Profile Companies Mentioned: - Ab Enzymes - Advanced Enzymes - Amano Enzymes - Dyadic International, Inc. - E.I. Dupont De Nemours & Company - Jiangsu Boli Bioproducts Co., Ltd - Novozymes - Royal Dsm - Solvay Enzymes - Specialty Enzymes & Biotechnologies Co. For more information visit http://www.researchandmarkets.com/research/dkhbw6/protein
Dyadic Added to Biofuel Digest Index of Bioeconomy Stocks
PR Newswire - Mon Jun 16, 3:15PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins, announced today that Biofuels Digest has selected Dyadic to be included in its Biofuel Digest Index as part of the annual rebalancing of publicly traded stocks included in the index. 
